N1F(Improved-Nephropathy 1 Formula) Ameliorates Renal Interstitial Fibrosis via Inhibiting Extracellular Matrix Deposition and Regulating the FGF23/P38MAPK/Wnt Pathway

pubmed: wnt1 2024-09-04

Summary:

CONCLUSIONS: N1F may exhibit potential therapeutic efficacy against renal fibrosis by inhibiting the FGF23/P38MAPK/Wnt signaling pathway, consequently inhibiting extracellular matrix deposition due to renal injury.

Link:

https://pubmed.ncbi.nlm.nih.gov/38722471/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=16uwQpOeqFYN8R4TKOtwPy2utpqy9ex2oldalD2yF_fQHv2caq&fc=None&ff=20240904113917&v=2.18.0.post9+e462414

From feeds:

Exome ยป pubmed: wnt1

Tags:

Authors:

Wenxiu Yu, Congcong Zeng, Chenggong Wang, Sining Jia, Chen Liu, Yini Zeng, Jinguo Cheng

Date tagged:

09/04/2024, 11:39

Date published:

05/09/2024, 06:00